Navigation Links
Media coverage affects how people perceive threat of disease: study
Date:10/29/2008

Hamilton, ON. October 29, 2008 Popular media coverage of infectious diseases greatly influences how people perceive those diseases, making them seem more dangerous, according to a new study from McMaster University.

The research, published online in the Public Library of Science: ONE, suggests diseases that show up frequently in the print media like bird flu are considered more serious than similar diseases that do not receive the same kind of coverage, such as yellow fever.

"The media tend to focus on rare and dramatic events," says Meredith Young, one of the study's lead authors and a graduate student in the Department of Psychology, Neuroscience & Behaviour. "When a certain disease receives repeated coverage in the press, people tend to focus on it and perceive it as a real threat. This raises concerns regarding how people view their own health, how they truly understand disease and how they treat themselves."

Researchers chose 10 infectious diseases drawn from the Centre for Disease Control database. Five were medical disorders that have been highly prevalent in the recent print media anthrax, SARS, West Nile virus, Lyme disease and avian flu and five were medical disorders that have not often been present in current media: Tularemia, human babesiosis, yellow fever, Lassa fever and hantavirus.

Two groups of students, undergraduate and medical students, were asked to rate how serious, how prevalent, and how "disease-like" various conditions were.

"We see that a single incident reported in the media, can cause great public concern if it is interpreted to mean that the potential risk is difficult to control, as with the possibility of a pandemic like in the case of Avian flu, and bioterrorism, as in the case of anthrax infection," says Young.

Conversely, when participants were presented with the descriptions of the disease, without the name, they actually thought that the diseases which received
'/>"/>

Contact: Michelle Donovan
donovam@mcmaster.ca
905-525-9140
McMaster University
Source:Eurekalert

Page: 1 2

Related medicine news :

1. AUDIO from Medialink and Radica: Staying Sharp with Games for Your Brain
2. AUDIO from Medialink and Kelloggs: Whats in Your Water?
3. AUDIO from Medialink and Commit Lozenge: Wanna Quit Smoking With Therapeutic Nicotine? Just Follow the Directions
4. AUDIO from Medialink and Pfizer: Number of Uninsured Americans Grows to 47 Million
5. Justice Department to Hold Media Event to Demonstrate New Database for Matching Unidentified Remains and Missing Persons Information
6. Weiner Public News First Media Team at National Press Club 5K
7. VIDEO from Medialink and General Motors: On and Off the Track
8. HealthMedia Revolution Explodes in Second Quarter
9. AUDIO from Medialink and Pfizer: Prescription for Safer Drugs Discussed in Washington
10. AUDIO from Medialink and Allergan: Women Not Sure Who to Trust on Anti-Aging Skin Care
11. AUDIO from Medialink and Pfizer: A New Prescription for Safer Drugs
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/5/2009)NEW ORLEANS, Dec. 5 Leukemia and myeloproliferative disorders are serious and often deadly blood cancers. Research presented today at the 51st Annual Meeting of the American Society of Hematology int
(Date:12/5/2009)The MAMA campaign is a collaborative effort by the National Association of Certified Professional Midwives (NACPM), Midwives Alliance of North America (MANA), Citizens for Midwifery (CfM), Internation
(Date:12/4/2009)SAN FRANCISCO, Dec. 4 Medithrive, Inc. has won the Patient,s Choice Award as the favorite dispensary in the SF Bay Area by popular vote conducted by the online website, www.weedmaps.com. Despite on
(Date:12/4/2009)MADISON HEIGHTS, Mich., Dec. 4 The Editorial Advisory and Securities Review Committee of BetterInvesting Magazine today announced Allergan, Inc. (NYSE: AGN ) as its February 2010 "Stock to Stud
(Date:12/4/2009)STANFORD, Calif. A new study shows that muscle cells grown in the lab can restore an intestine,s ability to squeeze shut properly. The work, performed in dogs and rats, might ultimately help treat pa
Breaking Medicine News(10 mins):Health News:Advances in Genetic Understanding and Treatment Protocols Lead to Significant Progress in Leukemia and Myeloproliferative Disorders 2Health News:Advances in Genetic Understanding and Treatment Protocols Lead to Significant Progress in Leukemia and Myeloproliferative Disorders 3Health News:Advances in Genetic Understanding and Treatment Protocols Lead to Significant Progress in Leukemia and Myeloproliferative Disorders 4Health News:Advances in Genetic Understanding and Treatment Protocols Lead to Significant Progress in Leukemia and Myeloproliferative Disorders 5Health News:Advances in Genetic Understanding and Treatment Protocols Lead to Significant Progress in Leukemia and Myeloproliferative Disorders 6Health News:Advances in Genetic Understanding and Treatment Protocols Lead to Significant Progress in Leukemia and Myeloproliferative Disorders 7Health News:Advances in Genetic Understanding and Treatment Protocols Lead to Significant Progress in Leukemia and Myeloproliferative Disorders 8Health News:Advances in Genetic Understanding and Treatment Protocols Lead to Significant Progress in Leukemia and Myeloproliferative Disorders 9Health News:AquaNatal Birth Center Gives Away a Waterbirth Package to Celebrate the Successful MAMA Campaign 2Health News:AquaNatal Birth Center Gives Away a Waterbirth Package to Celebrate the Successful MAMA Campaign 3Health News:AquaNatal Birth Center Gives Away a Waterbirth Package to Celebrate the Successful MAMA Campaign 4Health News:BetterInvesting Magazine Releases February Stock to Study and Undervalued Stock Choicesfor Investors' Informational and Educational Use 2Health News:Muscle cell infusion shown to strengthen sphincters in animals in Stanford study 2Health News:Muscle cell infusion shown to strengthen sphincters in animals in Stanford study 3Health News:Muscle cell infusion shown to strengthen sphincters in animals in Stanford study 4
... , , , , Wheelock becomes chair, McNerney is v... EAGAN, Minn., Feb. 13 The Blue Cross and Blue Sh...as elected new board leaders. Pamela Wheelock, vic...cently held the position of vice chair. Wheelock h...
...nds even without weight loss, general health, func...thDay News) -- Even if it doesn,t help them lose w... quality of life, a U.S. study shows. , It include... expenditure of 4 kilocalories per kilogram (2.2 p...
...RTLAND, Oregon, Feb. 13 Women,s Healthcare Associ... midwifery, maternal fetal,medicine and genetics p... has,been honored by the American Academy of Nurse..., received the honor in a recent ceremony. America...
... - Dr. Tommy Tomizawa of UCLA Medical Center will ...cs may be beneficial to the elderly - , , TORRANC...ulation expected to climb over 300% in the next 50...mizawa, Assistant Professor at the David Geffen Me...
... highest ionized serum calcium 3 times more likely...(HealthDay News) -- A newly identified biomarker f... to decide whether or not to undergo treatment for...ith the lowest levels, said researchers at Wake Fo...
...E, Feb. 13 Seattle native composer Mateo Messina,... has recently won a Grammy award for Best Compilat... Other Visual Media. The team of talented artists ...es such as Juno and Thank You for Smoking to t...
Other Medicine News:Health News:Blue Cross Board of Trustees Elects New Leadership 2Health News:Exercise Boosts Quality of Life in Postmenopausal Women 2Health News:Women's Healthcare Associates Midwife Winner of American Academy of Nurse Practitioners State Award of Excellence 2Health News:The Effects of Probiotics on the Aging Digestive Tract to be Presented at Nutracon 2009 2Health News:Researchers ID Biomarker for Fatal Prostate Cancer 2Health News:Seattle Native Composer's Work Wins Grammy Award 2
(Date:12/4/2009)LAKE FOREST, Ill., Dec. 4 Hospira, Inc. (NYSE: HSP ), a leading global specialty pharmaceutical and medication delivery company, today announced the launch of its next-generation 50 mL and 100 mL V
(Date:12/4/2009)HOUSTON, Dec. 4 OrthoAccel Technologies, Inc., developers of the AcceleDent System , which is an acceleration device to enhance orthodontics, announced the availability of a new Continuing Education
(Date:12/4/2009)WILMINGTON, Del., Dec. 4 AstraZeneca (NYSE: AZN ) today announced that the US Food and Drug Administration (FDA) has approved once-daily SEROQUEL XR® (quetiapine fumarate) Extended Release Tab
Breaking Medicine Technology:Hospira Expands VisIV(TM) Portfolio to Offer Complete Range of Environmentally Friendly I.V. Containers 2Hospira Expands VisIV(TM) Portfolio to Offer Complete Range of Environmentally Friendly I.V. Containers 3Hospira Expands VisIV(TM) Portfolio to Offer Complete Range of Environmentally Friendly I.V. Containers 4AcceleDent Science is Showcased in New Continuing Education Course Published by PennWell 2AcceleDent Science is Showcased in New Continuing Education Course Published by PennWell 3AcceleDent Science is Showcased in New Continuing Education Course Published by PennWell 4US FDA Approves SEROQUEL XR(R) For Add-On Treatment of Major Depressive Disorder 2US FDA Approves SEROQUEL XR(R) For Add-On Treatment of Major Depressive Disorder 3US FDA Approves SEROQUEL XR(R) For Add-On Treatment of Major Depressive Disorder 4US FDA Approves SEROQUEL XR(R) For Add-On Treatment of Major Depressive Disorder 5US FDA Approves SEROQUEL XR(R) For Add-On Treatment of Major Depressive Disorder 6US FDA Approves SEROQUEL XR(R) For Add-On Treatment of Major Depressive Disorder 7US FDA Approves SEROQUEL XR(R) For Add-On Treatment of Major Depressive Disorder 8US FDA Approves SEROQUEL XR(R) For Add-On Treatment of Major Depressive Disorder 9Sono Tek Announces Second Quarter Results 5398 1Sono Tek Announces Second Quarter Results 5398 2Sono Tek Announces Second Quarter Results 5398 3AvMed Covers H1N1 Flu Vaccine For Members 5395 1AvMed Covers H1N1 Flu Vaccine For Members 5395 2Allscripts and Sandata Partner to Enhance Quality in Home Care Agencies Nationwide 10323 1Allscripts and Sandata Partner to Enhance Quality in Home Care Agencies Nationwide 10323 2Allscripts and Sandata Partner to Enhance Quality in Home Care Agencies Nationwide 10323 3
...LVERN, Pa., Nov. 18 Arlington Medical Resources (...r the pharmaceutical and diagnostic,imaging indust... Privigen was,sold in the U.S. during the third qu...ravenous immune globulin (IVIG) and was launched i...ated from the blood plasma of thousands,of donors ...
...ndomized study will enroll newly diagnosed, elderl...Celator Pharmaceuticals today announced that the f...e 2 clinical study of CPX-351 (Cytarabine:Daunorub...agnosed acute myeloid leukemia (AML). , , The... the Weill Medical College of Cornell University ...
Other Medicine Technology:Over $10 Million of CSL Behring's Privigen Was Sold in the U.S. During the Third Quarter of 2008 2Celator(R) Pharmaceuticals Announces Enrollment of First Patient in Phase 2 Study with CPX-351 2Celator(R) Pharmaceuticals Announces Enrollment of First Patient in Phase 2 Study with CPX-351 3
...ratory and a worldwide leader in innovative labora...nsive test menu of highly complex and unique medic... by the University of Utah, ARUP Laboratories' cli...sity teaching hospitals and children's hospitals, ...
...ratory and a worldwide leader in innovative labora...nsive test menu of highly complex and unique medic... by the University of Utah, ARUP Laboratories' cli...sity teaching hospitals and children's hospitals, ...
...ratory and a worldwide leader in innovative labora...nsive test menu of highly complex and unique medic... by the University of Utah, ARUP Laboratories' cli...sity teaching hospitals and children's hospitals, ...
...ratory and a worldwide leader in innovative labora...nsive test menu of highly complex and unique medic... by the University of Utah, ARUP Laboratories' cli...sity teaching hospitals and children's hospitals, ...
Medicine Products: